NO (nitric oxide): The ring master (Q50785887)

19 March 2018

title

NO (nitric oxide): The ring master (English)

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

physiologic neovascularization

3 July 2024

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20800929

3 July 2024

author name string

Swaraj Sinha

1

1 reference

19 March 2018

Sree Rama Chaitanya Sridhara

2

1 reference

19 March 2018

Sundaramoorthy Srinivasan

3

1 reference

19 March 2018

Ajit Muley

4

1 reference

19 March 2018

Syamantak Majumder

5

1 reference

19 March 2018

Maniselvan Kuppusamy

6

1 reference

19 March 2018

Ravi Gupta

7

1 reference

19 March 2018

Suvro Chatterjee

8

1 reference

19 March 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20800929

3 July 2024

publication date

30 August 2010

1 reference

19 March 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0171933510001524?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

https://api.elsevier.com/content/article/PII:S0171933510001524?httpAccept=text/plain

3 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

European Journal of Cell Biology

3 July 2024

published in

1 reference

19 March 2018

volume

90

1 reference

19 March 2018

issue

1

1 reference

19 March 2018

page(s)

58-71

1 reference

19 March 2018

Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Nitric oxide augments fetal pulmonary artery endothelial cell angiogenesis in vitro

3 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Ring formation in cultures of rat aortic smooth muscle cells

3 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

A molecular basis for NO selectivity in soluble guanylate cyclase

3 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

3 July 2024

Bagging predictors

6

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells

3 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide

3 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change

3 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Atrial natriuretic peptide-initiated cGMP pathways regulate vasodilator-stimulated phosphoprotein phosphorylation and angiogenesis in vascular endothelium

3 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126.

3 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Embryonic and adult vasculogenesis

3 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation

3 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Angiogenesis: basic pathophysiology and implications for disease

3 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

3 July 2024

Angiogenesis in vitro

15

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability

3 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Pathophysiology of tumor neovascularization

3 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo

3 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro.

3 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Inhibitory effects of bevacizumab on angiogenesis and corneal neovascularization

3 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies

3 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Cadmium induced endothelial dysfunction: consequence of defective migratory pattern of endothelial cells in association with poor nitric oxide availability under cadmium challenge

3 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

3 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Cadmium attenuates bradykinin-driven nitric oxide production by interplaying with the localization pattern of endothelial nitric oxide synthase.

3 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Thalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclase

3 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells

3 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Monocrotaline pyrrole-induced megalocytosis of lung and breast epithelial cells: Disruption of plasma membrane and Golgi dynamics and an enhanced unfolded protein response

3 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Secreted frizzled-related protein 4: an angiogenesis inhibitor.

3 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase

3 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration.

3 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Overview of PDEs and their regulation

3 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway

3 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Soluble guanylyl cyclase activation promotes angiogenesis

3 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

cGMP-dependent and -independent angiogenesis-related properties of nitric oxide

3 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway

3 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo

3 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Nitric oxide activation of guanylyl cyclase in cells revisited

3 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Isolation and culture of pulmonary endothelial cells

3 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide

3 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

3 July 2024

eNOS at a glance

46

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Differences in reactivity of confluent and nonconfluent cultures of human endothelial cells toward thrombin-stimulated platelets or heparinized salt solution

3 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Myosin light chain kinase transference induces myosin light chain activation and endothelial hyperpermeability

3 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

3 July 2024

Nitric oxide donors

49

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat.

3 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Nitric oxide and angiogenesis

3 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models

3 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.EJCB.2010.07.005

3 July 2024

Identifiers

1 reference

19 March 2018

1 reference

19 March 2018